UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

Current Report Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

  

Date of Report (Date of earliest event reported): October 30, 2018

 

Blonder Tongue Laboratories, Inc.

(Exact Name of registrant as specified in its charter)

 

Delaware   1-14120   52-1611421
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (I.R.S. Employer
Identification No.)

 

One Jake Brown Road, Old Bridge, New Jersey    08857

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: (732) 679-4000

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company  ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On October 30, 2018, Blonder Tongue Laboratories, Inc. (the “Company”) issued a press release announcing the appointment of Edward R. “Ted” Grauch as the Company’s Executive Vice President and Chief Operating Officer.

 

In connection with his employment, Mr. Grauch will receive a base salary of $300,000 per year, and will be eligible to participate in the Company’s Executive Officer Salary Bonus Plan, subject to the terms of such plan, as determined by the Compensation Committee of the Board of Directors. He will also receive a signing bonus of $20,000, payable ninety days after his start date with the Company, and will be entitled to receive reimbursement of up to $8,500 per calendar year for personal air travel to and from his primary residence outside of New Jersey and a monthly automobile allowance of $750.00. In addition, Mr. Grauch will be granted (i) incentive stock options to acquire up to 150,000 shares of the Company’s common stock, with options covering 30,000 shares vesting on each of the first two anniversaries of the effective date of his employment, and options covering 45,000 shares vesting on each of the third and fourth anniversaries of the effective date of his employment and (ii) non-qualified stock options to acquire up to 350,000 shares of the Company’s common stock, with options covering 70,000 shares vesting on each of the first two anniversaries of the effective date of his employment, and options covering 105,000 shares vesting on each of the third and fourth anniversaries of the effective date of his employment. The non-qualified options granted are subject to accelerated vesting in the event of a change in control of the Company. Mr. Grauch also will be eligible to participate in other Company benefit plans and programs generally available to Company officers and/or employees.

 

There are no arrangements or understandings between Mr. Grauch and any other persons, pursuant to which he was appointed as an officer of the Company, no family relationships among any of the directors or executive officers of the Company, and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

 

The foregoing summary of the Letter Agreement is qualified in its entirety by reference to the complete text of the Letter Agreement, which is filed as Exhibits 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

A copy of the press release announcing Mr. Grauch’s appointment is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits. The following exhibit is filed herewith:

 

  Exhibit No.   Description
       
  10.1   Letter Agreement between Blonder Tongue Laboratories, Inc. and Edward R. Grauch.
       
  99.1   Press Release dated October 30, 2018.

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  BLONDER TONGUE LABORATORIES, INC.   
     
  By: /s/ Eric Skolnik
    Eric Skolnik
    Senior Vice President and Chief Financial Officer

 

Date: October 30, 2018

 

2

 

 

EXHIBIT INDEX

 

Exhibit No.   Description
     
10.1   Letter Agreement between Blonder Tongue Laboratories, Inc. and Edward R. Grauch.
     
99.1   Press Release dated October 30, 2018.

 

3

 

Exhibit 10.1

 

   

One Jake Brown Road

Old Bridge, New Jersey 08857

Tel: 732-679-4000

Fax: 732-679-4353

www.blondertongue.com

 

 

  

September 12, 2018

 

Mr. Edward R. (Ted) Grauch

3208 Hwy 98

Mexico Beach, FL 32456

 

Dear Ted:

 

On behalf of Blonder Tongue Laboratories, Inc. (the “Company”), I am pleased to offer you employment with our Company. We look forward to a successful working relationship providing the highest quality of products and services to our customers.

 

Your compensation, benefits, and other initial employment terms are summarized on the enclosed schedule.

 

On your first day of employment you should report to Bob Pallé and bring with you evidence of your legal authorization to work in the U.S. I enclose the Company’s Proprietary Information and Inventions Agreement, which you must sign and return prior to your first day of work .

 

By signing below, you are accepting employment and agreeing to all the terms of this letter and its enclosures, which supersede any prior agreements, representations, or discussions regarding your employment. The offer of employment set forth in this letter will be deemed withdrawn and of no force or effect if a copy of this letter is not countersigned by you and returned to the Company prior to the close of business on September 26, 2018.

 

We look forward to your joining our team.

 

  Sincerely,
   
  /s/ Eric Skolnik
  Eric Skolnik
  SVP & Chief Financial Officer

 

Accepted and Agreed:

 

/s/ Edward R. Grauch  
     
Dated: 26 September 2018  

 

Enc: Schedule of Compensation, Benefits, and Other Terms

Proprietary Information and Inventions Agreement

 

 

 

 

 

 

SCHEDULE OF COMPENSATION, BENEFITS, AND OTHER TERMS

 

Expected Start Date: October 29, 2018 (“ Start Date ”)

 

Position: Executive Vice President/Chief Operating Officer

Reports to CEO

Direct Reports –Engineering, Marketing & Sales

You will be based in Old Bridge, NJ

 

Salary: $300,000 per year rate (prorated for balance of 2018) and for 2019, less taxes and withholdings.

 

Signing Bonus You will be entitled to a signing bonus in the amount of $20,000, less taxes and withholdings, payable to you ninety days after your Start Date, so long as you remain employed by the Company through such date.

 

Car Allowance You will be entitled to receive a car allowance each month (prorated for any partial month) of your employment, which amount will be included as part of your compensation, in the amount of $750.00, minus the amount for such month of mileage reimbursement for business travel, at the applicable federal mileage reimbursement rate due to you, but such reimbursement shall not be in excess of $750.00 in any month.

 

Bonus Plan: Beginning with calendar year 2019, you will be eligible to participate in the Executive Officer Salary Bonus Plan, subject to the terms of the Plan, as determined by the Compensation Committee.

 

Equity Award: On the Start Date, you will be granted options to acquire 500,000 shares of Common Stock (“ Stock Options ”), with the grant date being the Start Date (“ Grant Date ”). The exercise price of your Stock Options will be set on the Grant Date, based on the arithmetic mean of the high and low selling price of the Company’s common stock on the Grant Date, as reported by the NYSE American Exchange (“ Exercise Price ”).

 

Your Stock Options will vest at the rate of 100,000 shares per year on each of the first two one-year anniversaries of the Grant Date and 150,000 shares per year on each of the third and fourth one-year anniversaries of the Grant Date, such that the first date on which any of the Stock Options will vest and be exercisable shall be on the first anniversary of the Grant Date, all as will be more fully set forth in Option Agreements that will be entered into with you as of the Grant Date.

 

  1  

 

 

A portion of your Stock Options will be Incentive Stock Options, as defined in Section 422 of the Internal Revenue Code of 1986, as amended (“ ISOs ”), under and pursuant to the Company’s 2016 Employee Equity Incentive Plan (“ 2016 Plan ”), subject to the following limitations: (i) first, Stock Options for no more than 250,000 shares of Common Stock may be granted to any individual in a single calendar year under the 2016 Plan, in accordance with the terms thereof, and (ii) second, under applicable federal tax law, the maximum number of Stock Options that can be ISOs granted under the 2016 Plan must be determined separately for each vesting year, and will be limited to the amount derived by dividing $100,000 by the Exercise Price per share, rounded down to the next whole number of shares. Subject to the foregoing limitations, it is agreed that on the first and second anniversaries of your Grant Date, you will receive ISOs to acquire 30,000 shares and on the third and fourth anniversaries of your Grant Date you will receive ISOs to acquire 45,000 shares.

 

The balance of the Stock Options (70,000 on the first and second anniversaries of your Grant Date and 105,000 on the third and fourth anniversaries of your Grant Date) will be granted to you as an inducement award in accordance with the requirements for such awards set forth in the New York Stock Exchange Listed Company Manual, and not pursuant to the 2016 Plan or any other shareholder-approved plan maintained by the Company; as such those Stock Options (sometimes referred to herein as “ Inducement Options ”) will not be ISOs. Vesting of your Inducement Options will be accelerated upon a change in control of the Company. For this purpose, “change in control of the Company” shall mean a change in control of such nature that it would be required to be reported to the Securities and Exchange Commission pursuant to Schedule 14A of Regulation 14A or any successor provision (whether or not the Company is then subject to such reporting requirements). A change of control will be deemed to have occurred if any person, other than persons or entities who on the date hereof are the “beneficial owners” (as determined pursuant to Sections 13(d) and 14(d) of the Securities Exchange Act of 1934), directly or indirectly, of securities of the Company representing 10% or more of the combined voting power of the Company’s then outstanding securities, is or becomes the “beneficial owner” of 25% or more of the combined voting power of the outstanding securities of the Company or if during two consecutive year periods, the directors at the beginning of such periods cease for any reason during the two-year period to constitute a majority of the Board of Directors of the Company.

 

All of the terms and conditions of your Stock Options will be set forth in Option Agreements that will be entered into with you as of the Grant Date, (a) in the case of ISOs, consistent with the provisions of the 2016 Plan, and (b) in the case of Inducement Options, consistent with prior similar grants by the Company to other executive employees, and in all cases, as otherwise approved by the Compensation Committee.

 

The shares underlying the Stock Options shall be subject to restrictions pursuant to Rule 144 under the Securities Act of 1933 as well as all other applicable securities laws as a result of your anticipated status as an executive officer of the Company and as a person subject to Section 16 of the Securities Exchange Act of 1934.

 

  2  

 

 

Travel Expenses: You will receive reimbursement of up to $8,500 per calendar year (pro rated for 2018) less taxes and withholdings, for personal air travel on weekends to and from you primary residence (in either Atlanta or Mexico Beach, FL). Receipts should be provided to Eric Skolnik. The personal air travel expense reimbursement will be treated as W-2 wages to you and taxes and other withholdings will be deducted on that basis, all in compliance with applicable law.

 

Paid Time Off: You will be eligible for (i) seven (7) vacation days during the remainder of calendar year 2018 and (ii) fifteen (15) vacation days per calendar year for each calendar year thereafter (or such greater number of days to which you may be entitled under the Company’s then standard employment policies) and (iii) up to six (6) sick days per year, in addition to Company-paid holidays.

 

Benefits: Eligibility to participate in the Company’s sponsored group health insurance coverage (medical, dental, vision), life insurance, and long-term disability plan commences on or about the Start Date, but in no event later than the first day of the calendar month following the Start Date. You will be eligible to participate in the Company’s 401(k) plan after six months of employment.

 

Status: Full-time employee. This position is not eligible for overtime as it is exempt from overtime under applicable law. You will be employed as an at-will employee, meaning either you or the Company can end the employment relationship at any time for any reason or no reason.

 

Work Location: You will be based in the Company’s Old Bridge, NJ office. However, your position will involve travel time away from the Company’s office from time to time. Any work-related injuries, even if sustained away from the office, are to be reported to the Company immediately. You must take all necessary and reasonable steps to safeguard the security of both electronic and paper records from unauthorized disclosure or damage, whether on-site or at a remote work location, and follow any applicable information technology or security policies relating thereto.

 

Company Standards: As an employee, you will be expected to adhere to the Company’s standards of professionalism, loyalty, integrity, honesty, and reliability. Employment is subject to all of the policies and procedures of the Company, as amended from time to time, including but not limited to the Code of Ethics, the Insider Trading Policy, and the Employee Handbook, copies of which are available upon request for your review. As an executive officer of a public company, you will also be subject to compliance with all applicable federal and state securities laws.

 

  3  

 

 

Third Party Agreements: You represent that you have provided to the Company (or the Company’s counsel) copies of any agreements with any current or former employers or other third parties that could restrict your ability to be employed or that limit the manner in which you may be employed. You further represent that you are not subject to any agreements with any current or former employers or other third parties that prevent you from accepting employment with the Company or performing the duties of your position. You agree not to bring to the Company or use in performing your duties for the Company any current or former employer or third party confidential or proprietary information or trade secrets. You also agree that you will not conduct yourself in a manner that would be violative of any such agreement with your current or former employers.

 

The Company has the right to modify the terms referenced herein at any time, consistent with any plan terms and applicable law. You acknowledge and agree that the Company has not provided you any legal or tax advice and that you have had a reasonable opportunity to consult with your own legal and tax advisors if you so choose.

 

  4  

Exhibit 99.1

 

 

One Jake Brown Road, Old Bridge NJ 08857

Phone: 732-679-4000 | Fax: 732-679-4353

www.blondertongue.com  | www.rldrake.com

 

 

FOR IMMEDIATE RELEASE:

 

Blonder Tongue Appoints Edward R. “Ted” Grauch as Executive Vice President
& Chief Operating Officer

 

OLD BRIDGE, NJ / October 30, 2018 / Blonder Tongue Laboratories, Inc . (NYSE American: BDR ) announced that the Company’s Board of Directors has appointed Edward R. “Ted” Grauch as its Executive Vice President and Chief Operating Officer.

 

Ted will report directly to Bob Pallé, the Company’s CEO and President, focusing on developing the Company’s product strategy, sales, marketing, and technology activities. The heads of each of those departments will report directly to Ted.

 

Ted, who holds an MBA from Johns Hopkins University, is also a degreed electrical and computer engineer and has more than 20 years of experience in executive level management and 30 years working in the video, internet and security services provider industries.

 

Immediately prior to joining Blonder Tongue, Ted served as President of Kaon USA, Inc., the US subsidiary of South Korea-based Kaonmedia Co., Ltd., the world’s fifth largest Set-Top and Broadband device manufacturer, where his responsibilities included all management, finance, technology marketing and differentiation, competing within the North American market as a major electronics supplier.

 

Commenting on Ted’s appointment, CEO and President, Bob Pallé said “We are extremely pleased that Ted has joined the Blonder Tongue team. Ted has a career history of effective highly motivated leadership, delivering revenue growth and bottom line results. He has a true entrepreneurial edge to him that will thrive in our environment, as work together to develop the blueprint for an aggressive plan to grow our Company and take it to the next level.”

 

Notable prior positions include over five years with Comcast Cable, serving as Vice President, Video CPE, Office of the CTO, where Ted’s team was responsible for Comcast’s nationwide residential video device strategy, including the design, development and deployment of many of Comcast’s X1 series Set-Top box platforms, ground breaking RF and Voice remote control programs, and national DTA device deployments. The DTA programs allowed Comcast to convert their network to 100% digital transmission by 2013.

 

Ted has also held several other executive positions, including VP, head of global marketing at ST Micro’s Advanced SoC video microprocessor division in Grenoble, France, Senior Vice President at Nagravision SA in Lausanne, Switzerland, from 2001 to 2009, and as an entrepreneur co-founder of Livewire, Inc, an engineering consulting firm he and his partners sold to Nagravision in 2001. Early in his career, Ted spent over five years as a senior electrical engineer with Scientific-Atlanta and also four years on engineering internship rotations at the National Security Agency (NSA) and for a US Defense Department contractor, during which time he held a US DoD TS Security Clearance.

 

Regarding his appointment as Chief Operating Officer, Ted Grauch said “With a rich history of innovation, and its reputation for highly reliable quality products, Blonder Tongue has a great potential for future growth. I’ve been impressed with our recently released NeXgen (NXG) flexible video and high-speed data delivery Platform. We have a great technology and engineering team at Blonder Tongue, along with world-class US based manufacturing and quality control organizations in place. I am very confident the Company is prepared to capitalize on many future opportunities in the market.”

 

 

 

 

In connection with Ted’s appointment as Chief Operating Officer, the Company has granted him (i) Incentive Stock Options under and pursuant to the Company’s 2016 Employee Equity Incentive Plan, to acquire up to 150,000 shares of the Company’s common stock, subject to time-based vesting conditions whereby 30,000 shares will vest on each of the next two anniversaries of the effective date of his employment, and 45,000 shares will vest on each of the third and fourth anniversaries of the effective date of his employment, provided that he remains an active employee of the Company on each such date; and (ii) an employment inducement award comprised of non-qualified stock options to acquire up to 350,000 shares of the Company’s common stock, subject to time-based vesting conditions, whereby 70,000 shares will vest on each of the next two anniversaries of the effective date of his employment and 105,000 shares will vest on each of the third and fourth anniversaries of the effective date of his employment, provided that he remains an active employee of the Company on each such date. The inducement award contains certain acceleration provisions in the event of a change in control. The inducement award of options to acquire shares of the Company’s common stock was made outside of the Company’s 2016 Employee Equity Incentive Plan and approved by the Compensation Committee of the Company’s Board of Directors in reliance on the employment inducement exception to shareholder approval provided under the NYSE American Company Guide, Section 711(a), which requires public announcement of inducement awards.

 

About Blonder Tongue

 

Blonder Tongue Laboratories, Inc. together with R. L. Drake Holdings, LLC - its wholly owned subsidiary - offer customers more than 130 years of combined engineering and manufacturing excellence with solid histories of delivering reliable, quality products. As a leader in the field of cable television communications, the Company provides system operators and integrators serving the cable, broadcast, satellite, IPTV, institutional and professional video markets with comprehensive solutions for the provision of content contribution, distribution and video delivery to homes and businesses. The Company designs, manufactures, sells and supports an equipment portfolio of standard and high definition digital video solutions, as well as core analog video and high speed data solutions for distribution over coax, fiber and IP networks. Additional information on the Company and its products can be found at www.blondertongue.com , and www.rldrake.com .

 

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: The information set forth above includes “forward-looking” statements and accordingly, the cautionary statements contained in Blonder Tongue’s Annual Report and Form 10-K for the year ended December 31, 2017. (See Item 1: Business, Item 1A: Risk Factors, Item 3: Legal Proceedings and Item 7: Management’s Discussion and Analysis of Financial Condition and Results of Operations), and other filings with the Securities and Exchange Commission are incorporated herein by reference. The words “believe”, “expect”, “anticipate”, “project”, “target”, “intend”, “plan”, “seek”, “estimate”, “endeavor”, “should”, “could”, “may” and similar expressions are intended to identify forward-looking statements. In addition, any statements that refer to projections for our future financial performance, our anticipated growth trends in our business and other characterizations of future events or circumstances are forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s analysis only as of the date hereof. Blonder Tongue undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof. Blonder Tongue’s actual results may differ from the anticipated results or other expectations expressed in Blonder Tongue’s “forward-looking” statements.

 

Contacts

 

Eric Skolnik
Chief Financial Officer
eskolnik@blondertongue.com
(732) 679-4000

 

Robert J. Pallé

Chief Executive Officer & President
bpalle@blondertongue.com
(732) 679-4000